Literature DB >> 17463249

Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.

Eleftheria Zeggini1, Michael N Weedon, Cecilia M Lindgren, Timothy M Frayling, Katherine S Elliott, Hana Lango, Nicholas J Timpson, John R B Perry, Nigel W Rayner, Rachel M Freathy, Jeffrey C Barrett, Beverley Shields, Andrew P Morris, Sian Ellard, Christopher J Groves, Lorna W Harries, Jonathan L Marchini, Katharine R Owen, Beatrice Knight, Lon R Cardon, Mark Walker, Graham A Hitman, Andrew D Morris, Alex S F Doney, Mark I McCarthy, Andrew T Hattersley.   

Abstract

The molecular mechanisms involved in the development of type 2 diabetes are poorly understood. Starting from genome-wide genotype data for 1924 diabetic cases and 2938 population controls generated by the Wellcome Trust Case Control Consortium, we set out to detect replicated diabetes association signals through analysis of 3757 additional cases and 5346 controls and by integration of our findings with equivalent data from other international consortia. We detected diabetes susceptibility loci in and around the genes CDKAL1, CDKN2A/CDKN2B, and IGF2BP2 and confirmed the recently described associations at HHEX/IDE and SLC30A8. Our findings provide insight into the genetic architecture of type 2 diabetes, emphasizing the contribution of multiple variants of modest effect. The regions identified underscore the importance of pathways influencing pancreatic beta cell development and function in the etiology of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17463249      PMCID: PMC3772310          DOI: 10.1126/science.1142364

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  20 in total

1.  Hex homeobox gene-dependent tissue positioning is required for organogenesis of the ventral pancreas.

Authors:  Roque Bort; Juan Pedro Martinez-Barbera; Rosa S P Beddington; Kenneth S Zaret
Journal:  Development       Date:  2004-01-21       Impact factor: 6.868

2.  Aligning multiple genomic sequences with the threaded blockset aligner.

Authors:  Mathieu Blanchette; W James Kent; Cathy Riemer; Laura Elnitski; Arian F A Smit; Krishna M Roskin; Robert Baertsch; Kate Rosenbloom; Hiram Clawson; Eric D Green; David Haussler; Webb Miller
Journal:  Genome Res       Date:  2004-04       Impact factor: 9.043

3.  A genome-wide association study identifies novel risk loci for type 2 diabetes.

Authors:  Robert Sladek; Ghislain Rocheleau; Johan Rung; Christian Dina; Lishuang Shen; David Serre; Philippe Boutin; Daniel Vincent; Alexandre Belisle; Samy Hadjadj; Beverley Balkau; Barbara Heude; Guillaume Charpentier; Thomas J Hudson; Alexandre Montpetit; Alexey V Pshezhetsky; Marc Prentki; Barry I Posner; David J Balding; David Meyre; Constantin Polychronakos; Philippe Froguel
Journal:  Nature       Date:  2007-02-11       Impact factor: 49.962

4.  Overexpression of insulin degrading enzyme: cellular localization and effects on insulin signaling.

Authors:  K A Seta; R A Roth
Journal:  Biochem Biophys Res Commun       Date:  1997-02-03       Impact factor: 3.575

5.  Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats.

Authors:  H Fakhrai-Rad; A Nikoshkov; A Kamel; M Fernström; J R Zierath; S Norgren; H Luthman; J Galli
Journal:  Hum Mol Genet       Date:  2000-09-01       Impact factor: 6.150

6.  The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.

Authors:  D Altshuler; J N Hirschhorn; M Klannemark; C M Lindgren; M C Vohl; J Nemesh; C R Lane; S F Schaffner; S Bolk; C Brewer; T Tuomi; D Gaudet; T J Hudson; M Daly; L Groop; E S Lander
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

7.  Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes.

Authors:  Anna L Gloyn; Michael N Weedon; Katharine R Owen; Martina J Turner; Bridget A Knight; Graham Hitman; Mark Walker; Jonathan C Levy; Mike Sampson; Stephanie Halford; Mark I McCarthy; Andrew T Hattersley; Timothy M Frayling
Journal:  Diabetes       Date:  2003-02       Impact factor: 9.461

8.  Characterization of the abnormal pancreatic development, reduced growth and infertility in Cdk4 mutant mice.

Authors:  Richard V Mettus; Sushil G Rane
Journal:  Oncogene       Date:  2003-11-20       Impact factor: 9.867

9.  Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein.

Authors:  Wesley Farris; Stefan Mansourian; Malcolm A Leissring; Elizabeth A Eckman; Lars Bertram; Christopher B Eckman; Rudolph E Tanzi; Dennis J Selkoe
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

10.  Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes.

Authors:  N Marzo; C Mora; M E Fabregat; J Martín; E F Usac; C Franco; M Barbacid; R Gomis
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

View more
  1033 in total

1.  Replication in genome-wide association studies.

Authors:  Peter Kraft; Eleftheria Zeggini; John P A Ioannidis
Journal:  Stat Sci       Date:  2009-11-01       Impact factor: 2.901

2.  Variants at the endocannabinoid receptor CB1 gene (CNR1) and insulin sensitivity, type 2 diabetes, and coronary heart disease.

Authors:  Jose M de Miguel-Yanes; Alisa K Manning; Peter Shrader; Jarred B McAteer; Anuj Goel; Anders Hamsten; Caroline S Fox; Jose C Florez; Josée Dupuis; James B Meigs
Journal:  Obesity (Silver Spring)       Date:  2011-06-02       Impact factor: 5.002

3.  Role of zinc in human islet amyloid polypeptide aggregation.

Authors:  Jeffrey R Brender; Kevin Hartman; Ravi Prakash Reddy Nanga; Nataliya Popovych; Roberto de la Salud Bea; Subramanian Vivekanandan; E Neil G Marsh; Ayyalusamy Ramamoorthy
Journal:  J Am Chem Soc       Date:  2010-07-07       Impact factor: 15.419

4.  The risk allele load accelerates the age-dependent decline in beta cell function.

Authors:  A Haupt; H Staiger; S A Schäfer; K Kirchhoff; M Guthoff; F Machicao; B Gallwitz; N Stefan; H-U Häring; A Fritsche
Journal:  Diabetologia       Date:  2009-01-27       Impact factor: 10.122

5.  Genotype-based matching to correct for population stratification in large-scale case-control genetic association studies.

Authors:  Weihua Guan; Liming Liang; Michael Boehnke; Gonçalo R Abecasis
Journal:  Genet Epidemiol       Date:  2009-09       Impact factor: 2.135

6.  Improving power of association tests using multiple sets of imputed genotypes from distributed reference panels.

Authors:  Wei Zhou; Lars G Fritsche; Sayantan Das; He Zhang; Jonas B Nielsen; Oddgeir L Holmen; Jin Chen; Maoxuan Lin; Maiken B Elvestad; Kristian Hveem; Goncalo R Abecasis; Hyun Min Kang; Cristen J Willer
Journal:  Genet Epidemiol       Date:  2017-09-01       Impact factor: 2.135

Review 7.  Linking diabetic vascular complications with LncRNAs.

Authors:  Amy Leung; Vishnu Amaram; Rama Natarajan
Journal:  Vascul Pharmacol       Date:  2018-02-03       Impact factor: 5.773

Review 8.  Epigenetics and obesity.

Authors:  Reinhard Stöger
Journal:  Pharmacogenomics       Date:  2008-12       Impact factor: 2.533

9.  Associations of genetic variants in/near body mass index-associated genes with type 2 diabetes: a systematic meta-analysis.

Authors:  Bo Xi; Fumihiko Takeuchi; Aline Meirhaeghe; Norihiro Kato; John C Chambers; Andrew P Morris; Yoon Shin Cho; Weihua Zhang; Karen L Mohlke; Jaspal S Kooner; Xiao Ou Shu; Hongwei Pan; E Shyong Tai; Haiyan Pan; Jer-Yuarn Wu; Donghao Zhou; Giriraj R Chandak
Journal:  Clin Endocrinol (Oxf)       Date:  2014-03-13       Impact factor: 3.478

Review 10.  Targeting the pancreatic β-cell to treat diabetes.

Authors:  Amedeo Vetere; Amit Choudhary; Sean M Burns; Bridget K Wagner
Journal:  Nat Rev Drug Discov       Date:  2014-02-14       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.